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ABSTRACT 
 
Background and Objectives: Hydrocortisone is widely used in septic shock cases resistant to fluid and vasopressor therapy. 
It may result in increased blood pressure and survival. However the efficacy is no established among patients with severe 
burn and septic shock. Accordingly it was assessed in this study.
Materials and Methods: The patients older than 14 years of age with resistant septic shock were enrolled during one-year 
period. The hydrocortisone was prescribed 100 mg three times per day and the alterations in systolic and diastolic blood 
pressures were recorded.
Results: Twenty-nine patients were enrolled including 19 men and 10 women. The mean age was 37 ± 19 years and the mean 
burn surface area was 60 ± 20. Fourteen patients had positive blood culture. The most common isolated microorganism were 
Pseudomonas aeuroginosa in 34.6%(10 cases), and then Acinetobacter in 13.8%(4 cases). The infection was from wound in 
79% and the remaining 21% had pneumonia. Twenty-one patients had good response to hydrocortisone and the increase in 
systolic and diastolic blood pressures was significant; but the mortality rate was similar.
Conclusion: Treatment with hydrocortisone would result in increase in systolic and diastolic blood pressure in burn patients 
with resistant septic shock. 
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deaths in these patients (1, 2). Septic shock is one of 
the most serious complications seen in 2 to 20 per-
cent of infection cases (3). Infection and related mor-
tality are affected by age, gender, type, and cause of 
burn (2). It is generally as wound infection and with 
less frequency it may be seen as sepsis, urinary tract 
infection, and pneumonia (4).
Use of hydrocortisone has been matter of debates 
for years. Hydrocortisone prescription is common 
for control of resistant hypotension cases, defined as 
septic shock persisting for minimally one hour de-
spite fluid-therapy and vasopressor medications, re-
sults in decreased mortality (1, 5). Some tests have 
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shown that hydrocortisone level in critically ill pa-
tients is low and use of hydrocortisone would low-
er the mortality rate (2). Also a study among burn 
patients demonstrated that low hydrocortisone levels 
(200-300 mg per day) would more rapidly alleviate 
the burn shock and decrease the mortality rate (3). 
All these studies reveal the improvement of shock 
patients who receive hydrocortisone. Accordingly, in 
this study the efficacy of hydrocortisone in burn pa-
tients with resistant septic shock was evaluated after 
shock was improved.
 
MATERIALS AND METHODS
 
   In this descriptive study, all eligible admitted pa-
tients were enrolled. The inclusion criteria were ag-
ing more than 14 years, established sepsis according 
to criteria (6), persistent shock despite fluid-therapy 
and vasopressor use for more than one hour, present-
ing as systolic blood pressure less than 90 mmHg or 
reduction of more than 40 mmHg in systolic blood 
pressure. The patients were excluded if had history 
of immunosuppression such as diabetes, AIDS and 
history of corticosteroid use in last six months.
The sampling was performed for blood culture and 
complete blood cell count. In addition to required 
antibiotics and other medications, fluid-therapy was 
performed with 1-2 liter of normal saline serum and 
also vasopressors were administered as dopamine 
with dose of 15-20 microgram per kilogram per min-
ute for one hour. In non-responding cases, the hydro-
cortisone 300 mg daily (Hydrocortisone Hemi-Suc-
cinate injection, 2 ml) was added.
For all patients, a checklist of demographic and 
clinical data (age, gender, burning percent, burning 
grade, burning cause, and inhalation burn) was ful-
filled. Also the blood pressure before and after treat-
ment, results of tests and blood cultures, type of pre-
existing disease, and origin of initial infection were 
recorded. The efficacy of hydrocortisone was defined 
as increase in systolic blood pressure to more than 90 
mmHg after treatment. This study was approved by 
local ethical committee.
Data analysis was performed among 29 subjects 
by SPSS (version 18.0) software [Statistical Proce-
dures for Social Sciences; Chicago, Illinois, USA]. 
Chi-Square and independent-sample-T tests were 
used and were considered statistically significant at 
P values less than 0.05.
 
RESULTS
The most common isolated microorganism was 
Pseudomonas aeuroginosa in 34.6% (10 cases), and 
then Acinetobacter in 13.8%(4 cases). Totally, 29 pa-
tients were enrolled including ten women (34.5%) 
and 19 men (65.5%). Demographic data are shown in 
Table 1. The most common cause of burn was gas ex-
plosion (14 patients), and then, gasoline (5 subjects), 
fire (3 patients), melting material (2 subjects), petro-
leum (2 patients), diesel (1 patient), alcohol (1 case), 
and scald burn (1 subject). Eight patients (27.6%) had 
positive history of preexisting diseases such as psy-
chological diseases, hypothyroidism, hypertension, 
and epilepsy. Also 21 patients had no history of pre-
existing disease.
Leukopenia (white blood cell count less than 
3500 per mm³), leukocytosis (white blood cell count 
more than 15000 per mm³), simultaneous leukope-
nia and thrombocytopenia, thrombocytopenia alone, 
and normal white blood cell count were seen in 11 
(37.9%), 4 (13.8%), 6 (20.7%), 3 (10.3%), and 5 pa-
tients (17.2%), respectively.
Twenty-one patients (72.4%) showed therapeu-
tic response to hydrocortisone and eight subjects 
(27.6%) had no response. Those with response in-
cluded 14 men and 7 women (Table 2). The age, gen-
der, burning percent, inhalation burn, and the other 
factors such as preexisting disease, type of contrib-
uting germ, and cause of infection, were not related 
to therapeutic response (Table 2). Also there was no 
difference in mortality rate among those with and 
without hydrocortisone response (P > 0.05).
 
 
DISCUSSION
In this study, the gas explosion and gasoline were 
the most common causes of burn. However, in ma-
jority of the other studies, fire and scald burn were 
the major causes (7-9). The difference may be due 
to cultural causes or feasibility of materials. In a 
systematic study by Brusselaers et al, preexisting 
disease was common especially cardiovascular and 
pulmonary diseases and diabetes (9). However in our 
study, the psychiatric diseases were the most com-
mon disorder that may be expected regarding high 
prevalence of suicide as the cause of burn.
The most common complications in burn patients 
are wound infection, respiratory problems (acute 
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respiratory distress syndrome), and septicemia (10). 
In this study, the most common cause of infection 
was wound infection and the pseudomonas was the 
most common isolated bacterium as well as other 
studies (10, 11).
In this study, the hydrocortisone was prescribed 
with daily dose of 300 mg for those with resistant 
septic shock (systolic blood pressure lower than 90 
mmHg despite one hour of fluid and vasopressor 
therapy). Hydrocortisone resulted in improvement of 
septic shock in burn patients, but the mortality was 
not decreased. In a similar study by Charles et al, the 
hydrocortisone had no effect on increase of the blood 
pressure in case and control groups and only resulted 
in shortening of shock improvement interval. It had 
no additional effect on reduction of mortality in first 
month of admission (3). In a study by Fox et al the 
corticosteroid both improved the shock and reduced 
the mortality rate.
In this study, the improvement of resistant shock 
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Table1. Demographic characteristics among the patients
Improved Not Improved P value
Male                        Female       Total                      P value
Age (Mean ± SD)                                              39 ± 18                   33 ± 22                    37 ± 19                     0.91
Burn Percent (Mean ± SD)                              59 ± 22                   66 ± 20                    60 ± 20                     0.99
Inhalation Burn                                                 10 (35%)                  7 (24%)                   17 (59%)     0.3
Blood Culture
Pseudomonas                                              7 (24%)                   3 (10%)                   10 (34%)                    0.3
Acinetobacter                                              1 (4%)                   3 (10%)                    4 (14%)
Negative                                                             10 (34%)                   4 (14%)                   15 (53%)
Infection Cause                                           
Wound                                                             13 (45%)                  10 (34%)                   23 (79%)                   0.17
Pneumonia                                              6 (21%)                    -------                   6 (21%)
Blood Pressure                       
Initial Systolic Blood Pressure              83 ± 8                   82 ± 9                   83 ± 8                       0.71
Initial Diastolic Blood Pressure              41 ± 6                   44 ± 9                  104 ± 18                    0.21
Final Systolic Blood Pressure             106 ± 20                  102 ± 11                   42 ± 7                       0.04
Final Diastolic Blood Pressure              62 ± 21                   58 ± 22                  61 ± 21                      0.90
Therapeutic Response                        14 (48%)                   7 (24%)                 21 (72%)                    0.58
Gender
Male
Female
Age (Year)
Burn Percent
Inhalation Burn
Blood Culture
Positive
Negative
Infection Cause
Wound
Pneumonia
14 (29%)
7 (24%)
37 ± 20
57 ± 20
11 (38%)
12 (41%)
9 (21%)
15 (52%)
6 (21%)
5 (17%)
3 (10%)
36 ± 18
68 ± 23
6 (21%)
2 (7%)
6 (21%)
8 (27%)
------
0.86
0.56
0.25
0.25
0.11
Table 2. Characteristics according to therapeutic response
Improved                  Not Improved                                   P value
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in patients who received hydrocortisone was signifi-
cant. Accordingly, use of hydrocortisone is definitely 
effective in treatment of resistant septic shock and 
this increase is not differed according to the age, 
gender, burning percent, and contributing factors for 
the burn. Hydrocortisone had no effect on mortality 
rate among patients.
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